Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes Erecta L. and its effects on Caenorhabditis Elegans fat storages

Núñez, Sonia ; Moliner, Cristina ; Valero, Marta Sofía (Universidad de Zaragoza) ; Mustafa, Ahmed M. ; Maggi, Filippo ; Gómez-Rincón, Carlota ; López, Víctor

Resumen: Diabetes mellitus (DM) is a metabolic disease characterized by a high blood sugar level that can cause severe complications to the organism or even death when not treated. However, certain dietary habits and foods may have beneficial effects on this condition. A polyphenolic-rich extract (containing hyperoside, isoquercitrin, quercetin, ellagic acid, and vanillic acid) of Tageres erecta L. (T. erecta) was obtained from yellow and orange flowers using an ethanolic Soxhlet extraction. These extracts were screened for antidiabetic and anti-obesity properties using in vitro and in vivo procedures. The capacity to inhibit the enzymes lipase and α-glucosidase, as well as the inhibition of advance glycation end-products (AGEs) was tested in vitro. Caenorhabditis elegans (C. elegans) was used as an obesity in vivo model to assess extracts effects on fat accumulation using the wild-type strain N2 and a mutant with no N3 fatty acid desaturase activity BX24. Extracts from both cultivars (yellow and orange) T. erecta presented in vitro inhibitory activity against the enzymes lipase and α-glucosidase, showing lower IC50 values than acarbose (control). They also showed important activity in preventing AGEs formation. The polyphenol-rich matrices reduced the fat content of obese worms in the wild-type strain (N2) down to levels of untreated C. elegans, with no significant differences found between negative control (100% reduction) and both tested samples (p < 0.05). Meanwhile, the fat reduction was considerably lower in the BX24 mutants (fat-1(wa-9)), suggesting that N3 fatty acid desaturase activity could be partially involved in the T. erecta flower effect. Our findings suggested that polyphenols from T. erecta can be considered candidate bioactive compounds in the prevention and improvement of metabolic chronic diseases such as obesity and diabetes.

Idioma: Inglés

DOI: 10.1007/s13105-023-00953-5

Año: 2023

Publicado en: Journal of Physiology and Biochemistry 79, 2 (2023), 427-440
ISSN: 1138-7548

Factor impacto JCR: 3.7 (2023)

Categ. JCR: PHYSIOLOGY rank: 17 / 85 = 0.2 (2023) - Q1 - T1
Categ. JCR: BIOCHEMISTRY & MOLECULAR BIOLOGY rank: 119 / 313 = 0.38 (2023) - Q2 - T2

Factor impacto CITESCORE: 6.6 - Biochemistry (Q2) - Physiology (Q2)

Factor impacto SCIMAGO: 0.953 - Medicine (miscellaneous) (Q1) - Physiology (Q2) - Biochemistry (Q2)

Financiación: info:eu-repo/grantAgreement/ES/DGA/B44-20D
Financiación: info:eu-repo/grantAgreement/ES/UZ/JIUZ-2021-BIO-08

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Fisiología (Dpto. Farmac.Fisiol.y Med.L.F.)